Viva 5 Corporation and Robinson Pharma Sign Agreement to Partner on Probiotic Softgels

FOR IMMEDIATE RELEASE
September 2015
Contact: Brian Baer
+1-561-239-2239

SUNRISE, FL (Sept 22, 2015) — Viva 5 Corporation, a US-based probiotic specialist, has formed a partnership with Robinson Pharma, a leading softgel manufacturing company, to help commercialize probiotic softgels worldwide. The five-year supply agreement allows Viva 5 to help commercialize a full line of probiotic softgels using Robinson Pharma’s softgel technology and manufacturing capabilities.

The probiotic softgel products will feature a unique probiotic called Bacillus Coagulans IS-2, or “Unique IS-2”, which can tolerate higher temperatures during manufacturing than traditional lactic acid bacteria, and has superior shelf life stability in finished products. As a result, the probiotic lends itself to a wider variety of delivery forms including soft gels. Having previously developed and commercialized probiotic gummies using the Unique IS-2 probiotic, Viva 5 will be now adding probiotic softgels as an additional delivery form to their probiotic portfolio.

“The partnership with Robinson Pharma represents an additional opportunity for us to work together in commercializing probiotic softgels,” says Brian Baer, President of Viva 5. “We are impressed with Robinson Pharma’s high quality softgel manufacturing process and commitment to product development. We believe the Unique IS-2 strain lends itself to a wide variety of formulations in soft gels due to its scientific support and superior stability over traditional commercial probiotic products. As a result, we expect to see high demand for probiotic softgel products.”

Viva 5 chose to partner with Robinson Pharma to take advantage of the largest softgel capacity in the United States, along with Robinson Pharma’s high quality manufacturing process and experience in working with probiotics. Robinson Pharma was the first company to create a shelf stable softgel. “We are quite excited to team up with Viva 5,” says Tuong Nguyen, Chief Executive Officer at Robinson Pharma. “With the continued high growth of probiotic sales in the industry, along with Viva 5’s proven track record to commercialize innovative products, we believe this partnership is ideal to help expand awareness and commercial success of our probiotic softgels.”

FOR FURTHER INFORMATION ABOUT VIVA 5 CORPORATION OR ROBINSON PHARMA, PLEASE CONTACT:

Brian Baer
President
Viva 5 Corporation
Ph: +1-561-239-2239

Tuong Nguyen
Chief Execut ive Of ficer
Robinson Pharma, Inc.
Ph: 1-714-241-0235

ABOUT VIVA 5 CORPORATION

Viva 5 Corporation is a US and International leader in sourcing, product development, manufacturing, regulatory &
marketing support for a variety of channels in the nutrition, health & beauty, and pharmaceutical industries. Viva 5
specialties include the development of innovative, proprietary and efficacious products that create incremental revenue opportunities for its distribution and retail partners worldwide.

For more information, please visit www.viva5corp.com or call 1-561-239-2239.

ABOUT ROBINSON PHARMA

Robinson Pharma, Inc. is a full-service contract manufacturer of softgels, tablets, capsules, powders, and liquids for the dietary supplements and personal health care industries. Through our innovative production methods, uncompromising attention to customer needs, and the conscientious efforts of our employees, no other company will be able to offer the combination of quality, price, and service that we provide.

For more information, please visit: www.robinsonpharma.com or call 1-714-241-0235.